AU2020309160B2 - Combination of ibuprofen and tramadol for relieving pain - Google Patents

Combination of ibuprofen and tramadol for relieving pain

Info

Publication number
AU2020309160B2
AU2020309160B2 AU2020309160A AU2020309160A AU2020309160B2 AU 2020309160 B2 AU2020309160 B2 AU 2020309160B2 AU 2020309160 A AU2020309160 A AU 2020309160A AU 2020309160 A AU2020309160 A AU 2020309160A AU 2020309160 B2 AU2020309160 B2 AU 2020309160B2
Authority
AU
Australia
Prior art keywords
ibuprofen
tramadol
combination
pain
comprised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020309160A
Other languages
English (en)
Other versions
AU2020309160A1 (en
Inventor
Carlos CALANDRIA PÉREZ
Ester DUART GONZALEZ
Fernando García Alonso
Antonia GÓMEZ CALVO
Raquel HORCAJADA CÓRDOBA
Ángel José MUÑOZ RUIZ
Antonio PORTOLÉS PÉREZ
María del Rosario SALAS BUTRÓN
Luis Narciso SANTÉ SERNA
Nuria SANZ MENÉNDEZ
Jose Angel SÁNCHEZ GARCÍA
Emilio VARGAS CASTRILLÓN
Marta Vicario De La Torre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Publication of AU2020309160A1 publication Critical patent/AU2020309160A1/en
Application granted granted Critical
Publication of AU2020309160B2 publication Critical patent/AU2020309160B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2020309160A 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain Active AU2020309160B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382583.3 2019-07-09
EP19382583 2019-07-09
PCT/EP2020/069306 WO2021005129A1 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Publications (2)

Publication Number Publication Date
AU2020309160A1 AU2020309160A1 (en) 2022-02-17
AU2020309160B2 true AU2020309160B2 (en) 2025-06-26

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020309160A Active AU2020309160B2 (en) 2019-07-09 2020-07-08 Combination of ibuprofen and tramadol for relieving pain

Country Status (21)

Country Link
US (1) US20220249414A1 (enExample)
EP (1) EP3996699B1 (enExample)
JP (1) JP7656339B2 (enExample)
CN (1) CN114080221B (enExample)
AU (1) AU2020309160B2 (enExample)
BR (1) BR112022000242A2 (enExample)
CA (1) CA3145632C (enExample)
DK (1) DK3996699T3 (enExample)
ES (1) ES2952013T3 (enExample)
FI (1) FI3996699T3 (enExample)
HR (1) HRP20230677T1 (enExample)
HU (1) HUE062529T2 (enExample)
MA (1) MA56341B1 (enExample)
MD (1) MD3996699T2 (enExample)
MX (1) MX2022000373A (enExample)
MY (1) MY207573A (enExample)
PL (1) PL3996699T3 (enExample)
PT (1) PT3996699T (enExample)
RS (1) RS64500B1 (enExample)
SI (1) SI3996699T1 (enExample)
WO (1) WO2021005129A1 (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2474309A1 (en) * 2009-09-04 2012-07-11 Farmalider, S.A. Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
ES2423866B1 (es) 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
GB2541571A (en) * 2014-04-10 2017-02-22 Charleston Laboratories Inc Pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2474309A1 (en) * 2009-09-04 2012-07-11 Farmalider, S.A. Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same

Also Published As

Publication number Publication date
BR112022000242A2 (pt) 2022-05-31
MA56341B1 (fr) 2023-07-31
SI3996699T1 (sl) 2023-10-30
JP7656339B2 (ja) 2025-04-03
ES2952013T3 (es) 2023-10-26
EP3996699A1 (en) 2022-05-18
DK3996699T3 (da) 2023-07-24
MD3996699T2 (ro) 2023-11-30
CA3145632C (en) 2024-03-12
CN114080221B (zh) 2023-12-05
EP3996699B1 (en) 2023-06-28
MY207573A (en) 2025-03-05
PL3996699T3 (pl) 2023-10-30
HUE062529T2 (hu) 2023-11-28
RS64500B1 (sr) 2023-09-29
CA3145632A1 (en) 2021-01-14
PT3996699T (pt) 2023-07-27
JP2022540854A (ja) 2022-09-20
US20220249414A1 (en) 2022-08-11
MX2022000373A (es) 2022-02-10
HRP20230677T1 (hr) 2023-10-13
WO2021005129A1 (en) 2021-01-14
AU2020309160A1 (en) 2022-02-17
CN114080221A (zh) 2022-02-22
FI3996699T3 (fi) 2023-08-01

Similar Documents

Publication Publication Date Title
KR102795284B1 (ko) 베타-히드록시부티레이트 및 부탄디올의 s-거울상이성질체 및 이의 사용 방법
RU2497512C2 (ru) Композиции на основе тапентадола для лечения боли
EP2148670B1 (en) Titration of tapentadol
US20090023744A1 (en) Combination therapy for depression
US20080026054A1 (en) Novel anelgesic combination
MXPA02011610A (es) Combinacion de sustancia activa que contiene un opioide que tiene una estructura tipo fentanilo y cetamina.
US20080031950A1 (en) Novel anelgesic combination
KR101816953B1 (ko) １-[２-(２,４-디메틸-페닐술파닐)페닐]-피페라진의 치료적 용도
KR20170091775A (ko) 정맥 내 투여용 이부프로펜의 투여
AU2020309160B2 (en) Combination of ibuprofen and tramadol for relieving pain
HK40067137A (en) Combination of ibuprofen and tramadol for relieving pain
HK40067137B (en) Combination of ibuprofen and tramadol for relieving pain
EP2004167A1 (en) Renin inhibitors for the treatment of hypertension
WO2013115737A2 (en) New pharmaceutical compositions of flurbiprofen and glucosamin
US20080058345A1 (en) Combination Therapy with Mecamylamine for the Treatment of Mood Disorders
TWI424850B (zh) 包含非類固醇類抗發炎藥物及秋水仙鹼甙(ｃｏｌｃｈｉｃｏｓｉｄｅ）衍生物之活性成分之新組合
CN100409850C (zh) 2h-[1,3]-噁嗪并[3,2-a]吲哚衍生物在制备治疗神经性疼痛的药物中的用途
JP2025109674A (ja) 疼痛および炎症に対するｎｓａｉｄとオピオイド鎮痛薬の相乗的で安定な医薬組成物
CN104284661A (zh) 包含(1r,4r)-6’-氟-N,N-二甲基-4-苯基-4’,9’-二氢-3’H-螺[环己烷-1,1’-吡喃并-[3,4,b]吲哚]-4-胺和水杨酸组分的药物组合物
KR20220110259A (ko) 통증 질환에 사용하기 위한 미르타자핀 및 티자니딘 배합물
HK1140939B (en) Tapentadol for treating pain from arthritis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)